Skip to main content

Profile hero

Profile details

Profil Jung Min (Joyce) Yeo

Joyce is an associate in our M&A practice in New York focusing on corporate and financial transactions.

 

Mandate

  • Roivant Sciences on its $7.1bn pending sale of Telavant to Roche.
  • CarLotz on its sale to Shift Technologies.
  • Zymergen on its pending $300 million sale to Ginkgo Bioworks—the first-ever sale of a publicly-listed public benefit corporation.
  • ams OSRAM on the sale of its North America-based digital systems business to Acuity Brands.
  • One Equity Partners portfolio company Spartronics on its acquisition of Primus Technologies Corp., a contract manufacturing and design business. 
  • Zymergen on its $575 million IPO, listing on Nasdaq, and conversion to a public benefit corporation and other corporate law matters.
  • Belden Inc. on the sale of its industrial cable business in Brazil to Yangtze Optical FC.

Qualifikationen

Education

  • Columbia Law School
    • J.D., 2020
    • Columbia Business Law Review
    • Harlan Fiske Stone Scholar
  • Georgetown University, School of Foreign Service
    • B.S., cum laude, May 2017